Ingevity Corp Appoints New Directors, Updates CFO Compensation
Ticker: NGVT · Form: 8-K · Filed: 2024-03-14T00:00:00.000Z
Sentiment: neutral
Topics: governance, executive-compensation, board-of-directors
Related Tickers: NGVT
TL;DR
NGVT adds 2 directors, inks new CFO pay deal.
AI Summary
On March 12, 2024, Ingevity Corporation (NGVT) announced changes to its Board of Directors and executive compensation. Specifically, the company elected two new directors, Douglas W. Smith and David L. Johnson, to its Board, effective immediately. Additionally, the company entered into a new employment agreement with its Chief Financial Officer, Katherine E. Butler, which includes updated compensation terms.
Why It Matters
The appointment of new directors and changes in executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance and executive compensation matters, with no immediate financial distress or significant operational changes indicated.
Key Players & Entities
- Ingevity Corporation (company) — Registrant
- Douglas W. Smith (person) — Newly elected director
- David L. Johnson (person) — Newly elected director
- Katherine E. Butler (person) — Chief Financial Officer
- March 12, 2024 (date) — Date of earliest event reported
FAQ
Who are the new directors appointed to Ingevity Corporation's Board?
Douglas W. Smith and David L. Johnson were elected as new directors to Ingevity Corporation's Board.
When were the new directors elected?
The new directors were elected effective immediately as of March 12, 2024.
What is the role of Katherine E. Butler at Ingevity Corporation?
Katherine E. Butler is the Chief Financial Officer of Ingevity Corporation.
What type of agreement did Ingevity Corporation enter into with its CFO?
Ingevity Corporation entered into a new employment agreement with its Chief Financial Officer, Katherine E. Butler.
What is the filing date for this Form 8-K?
This Form 8-K was filed on March 14, 2024, reporting events as of March 12, 2024.
Filing Stats: 522 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-03-14 16:32:03
Key Financial Figures
- $0.01 — ange on which registered Common Stock ($0.01 par value) NGVT New York Stock Exchange
Filing Documents
- ngvt-20240312.htm (8-K) — 26KB
- ngvt-20240312_g1.jpg (GRAPHIC) — 143KB
- 0001653477-24-000033.txt ( ) — 437KB
- ngvt-20240312.xsd (EX-101.SCH) — 2KB
- ngvt-20240312_lab.xml (EX-101.LAB) — 21KB
- ngvt-20240312_pre.xml (EX-101.PRE) — 12KB
- ngvt-20240312_htm.xml (XML) — 3KB
01. FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits. Exhibit No. Description of Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INGEVITY CORPORATION (Registrant) By: /S/ STACY L. COZAD Stacy L. Cozad Executive Vice President, General Counsel and Secretary Date: March 14, 2024